Ji, X. et al. Butyrate stimulates hepatic gluconeogenesis in mouse primary hepatocytes. Exp. Ther. Med. 17, 1677–1687 (2019).
Hong, Y.-H. et al. Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology 146, 5092–5099 (2005).
Chambers, E. S. et al. Acute oral sodium propionate supplementation raises resting energy expenditure and lipid oxidation in fasted humans. Diabetes Obes. Metab. 20, 1034–1039 (2018).
Pham, N. H. T. et al. Short-chain fatty acids and insulin sensitivity: a systematic review and meta-analysis. Nutr. Rev. 82, 193–209 (2024).
Psichas, A. et al. The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. Int. J. Obes. 39, 424–429 (2015).
Ge, H. et al. Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology 149, 4519–4526 (2008).
Bellahcene, M. et al. Male mice that lack the G-protein-coupled receptor GPR41 have low energy expenditure and increased body fat content. Br. J. Nutr. 109, 1755–1764 (2013).
Park, J. et al. Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR–S6K pathway. Mucosal Immunol. 8, 80–93 (2015).
Huang, C., Du, W., Ni, Y., Lan, G. & Shi, G. The effect of short-chain fatty acids on M2 macrophages polarization in vitro and in vivo. Clin. Exp. Immunol. 207, 53–64 (2022).
Inamoto, T. et al. Short-chain fatty acids stimulate dendrite elongation in dendritic cells by inhibiting histone deacetylase. FEBS J. 290, 5794–5810 (2023).
Frost, G. et al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat. Commun. 5, 3611 (2014).
Caetano-Silva, M. E. et al. Inhibition of inflammatory microglia by dietary fiber and short-chain fatty acids. Sci. Rep. 13, 2819 (2023).
Shen, H. et al. Gut microbiota modulates depressive-like behaviors induced by chronic ethanol exposure through short-chain fatty acids. J. Neuroinflammation 21, 290 (2024).
Kim, K. N., Yao, Y. & Ju, S. Y. Short chain fatty acids and fecal microbiota abundance in humans with obesity: a systematic review and meta-analysis. Nutrients 11, 2512 (2019).
Sanna, S. et al. Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nat. Genet. 51, 600–605 (2019).
Li, X. et al. Short-chain fatty acids in nonalcoholic fatty liver disease: new prospects for short-chain fatty acids as therapeutic targets. Heliyon 10, e26991 (2024).
Takahashi, K. et al. Reduced abundance of butyrate-producing bacteria species in the fecal microbial community in Crohn’s disease. Digestion 93, 59–65 (2016).
Chen, S.-J. et al. Association of fecal and plasma levels of short-chain fatty acids with gut microbiota and clinical severity in patients with Parkinson disease. Neurology 98, e848–e858 (2022).
Hou, K. et al. Microbiota in health and diseases. Signal Transduct. Target. Ther. 7, 135 (2022).
Culp, E. J. & Goodman, A. L. Cross-feeding in the gut microbiome: ecology and mechanisms. Cell Host Microbe 31, 485–499 (2023).
Morrison, D. J. & Preston, T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 7, 189–200 (2016).
Ze, X., Le Mougen, F., Duncan, S. H., Louis, P. & Flint, H. J. Some are more equal than others: the role of ‘keystone’ species in the degradation of recalcitrant substrates. Gut Microbes 4, 236–240 (2013).
Zhao, S., Lau, R., Zhong, Y. & Chen, M.-H. Lactate cross-feeding between Bifidobacterium species and Megasphaera indica contributes to butyrate formation in the human colonic environment. Appl. Environ. Microbiol. 90, e0101923 (2024).
Hosmer, J., McEwan, A. G. & Kappler, U. Bacterial acetate metabolism and its influence on human epithelia. Emerg. Top. Life Sci. 8, 1–13 (2024).
Bloemen, J. G. et al. Short chain fatty acids exchange across the gut and liver in humans measured at surgery. Clin. Nutr. 28, 657–661 (2009).
Zhang, S.-M. & Huang, S.-L. The commensal anaerobe Veillonella dispar reprograms its lactate metabolism and short-chain fatty acid production during the stationary phase. Microbiol. Spectr. 11, e0355822 (2023).
Reichardt, N. et al. Phylogenetic distribution of three pathways for propionate production within the human gut microbiota. ISME J. 8, 1323–1335 (2014).
Louis, P. & Flint, H. J. Formation of propionate and butyrate by the human colonic microbiota. Environ. Microbiol. 19, 29–41 (2017).
Cummings, J. H., Pomare, E. W., Branch, W. J., Naylor, C. P. & MacFarlane, G. T. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28, 1221–1227 (1987).
Fleming, S. E., Fitch, M. D. & Chansler, M. W. High-fiber diets: influence on characteristics of cecal digesta including short-chain fatty acid concentrations and pH. Am. J. Clin. Nutr. 50, 93–99 (1989).
Marsono, Y., Illman, R. J., Clarke, J. M., Trimble, R. P. & Topping, D. L. Plasma lipids and large bowel volatile fatty acids in pigs fed on white rice, brown rice and rice bran. Br. J. Nutr. 70, 503–513 (1993).
Topping, D. L. et al. Dietary fat and fiber alter large bowel and portal venous volatile fatty acids and plasma cholesterol but not biliary steroids in pigs. J. Nutr. 123, 133–143 (1993).
Bird, A. R. et al. Coarse brown rice increases fecal and large bowel short-chain fatty acids and starch but lowers calcium in the large bowel of pigs. J. Nutr. 130, 1780–1787 (2000).
Bloemen, J. G. et al. Short chain fatty acids exchange: is the cirrhotic, dysfunctional liver still able to clear them? Clin. Nutr. 29, 365–369 (2010).
Rowland, I. et al. Gut microbiota functions: metabolism of nutrients and other food components. Eur. J. Nutr. 57, 1–24 (2018).
Dagbasi, A., Lett, A. M., Murphy, K. & Frost, G. Understanding the interplay between food structure, intestinal bacterial fermentation and appetite control. Proc. Nutr. Soc. 79, 514–530 (2020).
Kastl, A. J. Jr., Terry, N. A., Wu, G. D. & Albenberg, L. G. The structure and function of the human small intestinal microbiota: current understanding and future directions. Cell. Mol. Gastroenterol. Hepatol. 9, 33–45 (2020).
Nireeksha, Luke, A. M., Kumari N, S., Hegde, M. N. & Hegde, N. N. Metabolic interplay of SCFA’s in the gut and oral microbiome: a link to health and disease. Front. Oral Health 6, 1646382 (2025).
Devarakonda, S. L. S. et al. Gut microbial features and dietary fiber intake predict gut microbiota response to resistant starch supplementation. Gut Microbes 16, 2367301 (2024).
Regard, J. B., Sato, I. T. & Coughlin, S. R. Anatomical profiling of G protein-coupled receptor expression. Cell 135, 561–571 (2008).
Ang, Z. et al. Human and mouse monocytes display distinct signalling and cytokine profiles upon stimulation with FFAR2/FFAR3 short-chain fatty acid receptor agonists. Sci. Rep. 6, 34145 (2016).
Xiong, Y. et al. Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc. Natl Acad. Sci. USA 101, 1045–1050 (2004).
Ruhnke, N. et al. Expression of free fatty acid receptor 2 in normal and neoplastic tissues. Exp. Mol. Pathol. 137, 104902 (2024).
Nøhr, M. K. et al. Expression of the short chain fatty acid receptor GPR41/FFAR3 in autonomic and somatic sensory ganglia. Neuroscience 290, 126–137 (2015).
Smith, P. M. et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569–573 (2013).
Kimura, I. et al. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat. Commun. 4, 1829 (2013).
Chambers, E. S. et al. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut 64, 1744–1754 (2015).
Kimura, I. et al. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc. Natl Acad. Sci. USA 108, 8030–8035 (2011).
Chung, W. S. F. et al. Modulation of the human gut microbiota by dietary fibres occurs at the species level. BMC Biol. 14, 3 (2016).
Brown, I. Complex carbohydrates and resistant starch. Nutr. Rev. 54, S115–S119 (1996).
Raigond, P., Ezekiel, R. & Raigond, B. Resistant starch in food: a review. J. Sci. Food Agric. 95, 1968–1978 (2015).
Flint, H. J., Scott, K. P., Duncan, S. H., Louis, P. & Forano, E. Microbial degradation of complex carbohydrates in the gut. Gut Microbes 3, 289–306 (2012).
Arumugam, M. et al. Enterotypes of the human gut microbiome. Nature 473, 174–180 (2011).
MacFarlane, G. T. & MacFarlane, S. Factors affecting fermentation reactions in the large bowel. Proc. Nutr. Soc. 52, 367–373 (1993).
Harris, H. C., Morrison, D. J. & Edwards, C. A. Impact of the source of fermentable carbohydrate on SCFA production by human gut microbiota in vitro—a systematic scoping review and secondary analysis. Crit. Rev. Food Sci. Nutr. 61, 3892–3903 (2021).
Campbell, J. M., Fahey, G. C. Jr. & Wolf, B. W. Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats. J. Nutr. 127, 130–136 (1997).
Haenen, D. et al. A diet high in resistant starch modulates microbiota composition, SCFA concentrations, and gene expression in pig intestine. J. Nutr. 143, 274–283 (2013).
den Besten, G. et al. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res. 54, 2325–2340 (2013).
Vinelli, V. et al. Effects of dietary fibers on short-chain fatty acids and gut microbiota composition in healthy adults: a systematic review. Nutrients 14, 2559 (2022).
Jardon, K. M., Canfora, E. E., Goossens, G. H. & Blaak, E. E. Dietary macronutrients and the gut microbiome: a precision nutrition approach to improve cardiometabolic health. Gut 71, 1214–1226 (2022).
Duncan, S. H., Louis, P., Thomson, J. M. & Flint, H. J. The role of pH in determining the species composition of the human colonic microbiota. Environ. Microbiol. 11, 2112–2122 (2009).
MacFarlane, G. T., Cummings, J. H. & Allison, C. Protein degradation by human intestinal bacteria. J. Gen. Microbiol. 132, 1647–1656 (1986).
Oliphant, K. & Allen-Vercoe, E. Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health. Microbiome 7, 91 (2019).
Geboes, K. P. et al. The influence of inulin on the absorption of nitrogen and the production of metabolites of protein fermentation in the colon. Br. J. Nutr. 96, 1078–1086 (2006).
Beaumont, M. et al. Quantity and source of dietary protein influence metabolite production by gut microbiota and rectal mucosa gene expression: a randomized, parallel, double-blind trial in overweight humans. Am. J. Clin. Nutr. 106, 1005–1019 (2017).
Reimer, R. A. et al. Inulin-type fructans and whey protein both modulate appetite but only fructans alter gut microbiota in adults with overweight/obesity: a randomized controlled trial. Mol. Nutr. Food Res. 61, 1700484 (2017).
Annunziata, G., Arnone, A., Ciampaglia, R., Tenore, G. C. & Novellino, E. Fermentation of foods and beverages as a tool for increasing availability of bioactive compounds. Focus on short-chain fatty acids. Foods 9, 999 (2020).
Vilar, E. G. et al. Mediterranean diet effect on the intestinal microbiota, symptoms, and markers in patients with functional gastrointestinal disorders. Microorganisms 12, 1969 (2024).
So, D., Loughman, A. & Staudacher, H. M. Effects of a low FODMAP diet on the colonic microbiome in irritable bowel syndrome: a systematic review with meta-analysis. Am. J. Clin. Nutr. 116, 943–952 (2022).
Akansel, M. G. et al. Effects of the ketogenic diet on microbiota composition and short-chain fatty acids in women with overweight/obesity. Nutrients 16, 4374 (2024).
Ferraris, C. et al. One month of classic therapeutic ketogenic diet decreases short chain fatty acids production in epileptic patients. Front. Nutr. 8, 613100 (2021).
Wan, Y. et al. Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: a 6-month randomised controlled-feeding trial. Gut 68, 1417–1429 (2019).
David, L. A. et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505, 559–563 (2014).
Yaoita, F. et al. Impact of habitual chewing on gut motility via microbiota transition. Sci. Rep. 12, 13819 (2022).
Müller, M. et al. Distal colonic transit is linked to gut microbiota diversity and microbial fermentation in humans with slow colonic transit. Am. J. Physiol. Gastrointest. Liver Physiol. 318, G361–G369 (2020).
Tazoe, H. et al. Expression of short-chain fatty acid receptor GPR41 in the human colon. Biomed. Res. 30, 149–156 (2009).
Karaki, S.-I. et al. Expression of the short-chain fatty acid receptor, GPR43, in the human colon. J. Mol. Histol. 39, 135–142 (2008).
Singh, N. et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40, 128–139 (2014).
Zou, F. et al. Effects of short-chain fatty acids in inhibiting HDAC and activating p38 MAPK are critical for promoting B10 cell generation and function. Cell Death Dis. 12, 582 (2021).
Brown, A. J. et al. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 278, 11312–11319 (2003).
Cook, T. M. et al. Vagal neuron expression of the microbiota-derived metabolite receptor, free fatty acid receptor (FFAR3), is necessary for normal feeding behavior. Mol. Metab. 54, 101350 (2021).
Hung, C.-C. et al. The intestinal fatty acid propionate inhibits Salmonella invasion through the post-translational control of HilD. Mol. Microbiol. 87, 1045–1060 (2013).
O’Riordan, K. J. et al. Short chain fatty acids: microbial metabolites for gut–brain axis signalling. Mol. Cell. Endocrinol. 546, 111572 (2022).
Tran, S. M.-S. & Mohajeri, M. H. The role of gut bacterial metabolites in brain development, aging and disease. Nutrients 13, 732 (2021).
Schmidt, J. et al. Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3. J. Biol. Chem. 286, 10628–10640 (2011).
Hudson, B. D. et al. Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs. FASEB J. 26, 4951–4965 (2012).
Milligan, G., Shimpukade, B., Ulven, T. & Hudson, B. D. Complex pharmacology of free fatty acid receptors. Chem. Rev. 117, 67–110 (2017).
Priyadarshini, M., Kotlo, K. U., Dudeja, P. K. & Layden, B. T. Role of short chain fatty acid receptors in intestinal physiology and pathophysiology. Compr. Physiol. 8, 1091–1115 (2018).
Taggart, A. K. P. et al. (d)-β-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J. Biol. Chem. 280, 26649–26652 (2005).
Pluznick, J. L. et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc. Natl Acad. Sci. USA 110, 4410–4415 (2013).
Nishida, A., Miyamoto, J., Shimizu, H. & Kimura, I. Gut microbial short-chain fatty acids-mediated olfactory receptor 78 stimulation promotes anorexigenic gut hormone peptide YY secretion in mice. Biochem. Biophys. Res. Commun. 557, 48–54 (2021).
Ikeda, T. et al. The free fatty acid receptor GPR164 maintains intestinal homeostasis and barrier function. EMBO Rep. 26, 5905–5930 (2025).
Barki, N. et al. Phosphorylation bar-coding of free fatty acid receptor 2 is generated in a tissue-specific manner. eLife 12, RP91861 (2023).
Ang, Z., Xiong, D., Wu, M. & Ding, J. L. FFAR2–FFAR3 receptor heteromerization modulates short-chain fatty acid sensing. FASEB J. 32, 289–303 (2018).
Lee, S. U. et al. β-Arrestin 2 mediates G protein-coupled receptor 43 signals to nuclear factor-κB. Biol. Pharm. Bull. 36, 1754–1759 (2013).
Caengprasath, N. et al. Internalization-dependent free fatty acid receptor 2 signaling is essential for propionate-induced anorectic gut hormone release. iScience 23, 101449 (2020).
Jean-Alphonse, F. et al. Spatially restricted G protein-coupled receptor activity via divergent endocytic compartments. J. Biol. Chem. 289, 3960–3977 (2014).
Sposini, S. et al. Integration of GPCR signaling and sorting from very early endosomes via opposing APPL1 mechanisms. Cell Rep. 21, 2855–2867 (2017).
Hirdaramani, A., Cheng, C.-W., Hanyaloglu, A. C. & Frost, G. A selective and augmentable butyrate–FFAR2 signal circuitry programs the cellular identity of enteroendocrine L-cells. Commun. Biol. 9, 606 (2026).
Bolognini, D., Tobin, A. B., Milligan, G. & Hodge, D. The pharmacology and function of receptors for short-chain fatty acids. Mol. Pharmacol. 89, 388–398 (2016).
Caengprasath, N. & Hanyaloglu, A. C. Hardwiring wire-less networks: spatially encoded GPCR signaling in endocrine systems. Curr. Opin. Cell Biol. 57, 77–82 (2019).
Lu, Y. et al. Effects of SCFA on the DNA methylation pattern of adiponectin and resistin in high-fat-diet-induced obese male mice. Br. J. Nutr. 120, 385–392 (2018).
Xie, A. et al. Bacterial butyrate in Parkinson’s disease is linked to epigenetic changes and depressive symptoms. Mov. Disord. 37, 1644–1653 (2022).
Wang, L. et al. Butyrate drives metabolic rewiring and epigenetic reprogramming in human colon cancer cells. Mol. Nutr. Food Res. 66, e2200028 (2022).
de Haan, J. B., Gevers, W. & Parker, M. I. Effects of sodium butyrate on the synthesis and methylation of DNA in normal cells and their transformed counterparts. Cancer Res. 46, 713–716 (1986).
Nshanian, M. et al. Short-chain fatty acid metabolites propionate and butyrate are unique epigenetic regulatory elements linking diet, metabolism and gene expression. Nat. Metab. 7, 196–211 (2025).
Silva, L. G., Ferguson, B. S., Avila, A. S. & Faciola, A. P. Sodium propionate and sodium butyrate effects on histone deacetylase (HDAC) activity, histone acetylation, and inflammatory gene expression in bovine mammary epithelial cells. J. Anim. Sci. 96, 5244–5252 (2018).
Lamas, A., Regal, P., Vázquez, B., Cepeda, A. & Franco, C. M. Short chain fatty acids commonly produced by gut microbiota influence Salmonella enterica motility, biofilm formation, and gene expression. Antibiotics 8, 265 (2019).
Zhang, S. et al. Short chain fatty acids modulate the growth and virulence of pathosymbiont Escherichia coli and host response. Antibiotics 9, 462 (2020).
Gantois, I. et al. Butyrate specifically down-regulates Salmonella pathogenicity island 1 gene expression. Appl. Environ. Microbiol. 72, 946–949 (2006).
Zhan, Z., Tang, H., Zhang, Y., Huang, X. & Xu, M. Potential of gut-derived short-chain fatty acids to control enteric pathogens. Front. Microbiol. 13, 976406 (2022).
Cheng, J. et al. Gut microbiota-derived short-chain fatty acids and depression: deep insight into biological mechanisms and potential applications. Gen. Psychiatr. 37, e101374 (2024).
Cao, M., Zhang, Z., Han, S. & Lu, X. Butyrate inhibits the proliferation and induces the apoptosis of colorectal cancer HCT116 cells via the deactivation of mTOR/S6K1 signaling mediated partly by SIRT1 downregulation. Mol. Med. Rep. 19, 3941–3947 (2019).
Zhang, Q. et al. Sodium butyrate blocks the growth of colorectal cancer by inhibiting the aerobic glycolysis mediated by SIRT4/HIF-1α. Chem. Biol. Interact. 403, 111227 (2024).
Wang, S. et al. Treatment with butyrate alleviates dextran sulfate sodium and Clostridium difficile-induced colitis by preventing activity of Th17 cells via regulation of SIRT1/mTOR in mice. J. Nutr. Biochem. 111, 109155 (2023).
Yi, G. et al. Soybean genistin-driven gut microbiota-derived butyrate synthesis activates the SIRT1 signaling pathway to ameliorate metabolic fatty liver. Free Radic. Biol. Med. 239, 336–351 (2025).
Ye, K., Zhao, Y., Huang, W. & Zhu, Y. Sodium butyrate improves renal injury in diabetic nephropathy through AMPK/SIRT1/PGC-1α signaling pathway. Sci. Rep. 14, 17867 (2024).
Cherta-Murillo, A. et al. The effects of SCFAs on glycemic control in humans: a systematic review and meta-analysis. Am. J. Clin. Nutr. 116, 335–361 (2022).
Jørgensen, J. R., Clausen, M. R. & Mortensen, P. B. Oxidation of short and medium chain C2–C8 fatty acids in Sprague-Dawley rat colonocytes. Gut 40, 400–405 (1997).
Clausen, M. R. & Mortensen, P. B. Kinetic studies on the metabolism of short-chain fatty acids and glucose by isolated rat colonocytes. Gastroenterology 106, 423–432 (1994).
De Vadder, F. et al. Microbiota-generated metabolites promote metabolic benefits via gut–brain neural circuits. Cell 156, 84–96 (2014).
Ma, J., Piao, X., Mahfuz, S., Long, S. & Wang, J. The interaction among gut microbes, the intestinal barrier and short chain fatty acids. Anim. Nutr. 9, 159–174 (2022).
He, K.-Y. et al. Akkermansia muciniphila protects the intestine from irradiation-induced injury by secretion of propionic acid. Gut Microbes 15, 2293312 (2023).
Suzuki, T., Yoshida, S. & Hara, H. Physiological concentrations of short-chain fatty acids immediately suppress colonic epithelial permeability. Br. J. Nutr. 100, 297–305 (2008).
Wang, W. et al. Butyrate and propionate are microbial danger signals that activate the NLRP3 inflammasome in human macrophages upon TLR stimulation. Cell Rep. 43, 114736 (2024).
Ichikawa, H. & Sakata, T. Stimulation of epithelial cell proliferation of isolated distal colon of rats by continuous colonic infusion of ammonia or short-chain fatty acids is nonadditive. J. Nutr. 128, 843–847 (1998).
Jiang, L. et al. Sodium butyrate alleviates lipopolysaccharide-induced inflammatory responses by down-regulation of NF-κB, NLRP3 signaling pathway, and activating histone acetylation in bovine macrophages. Front. Vet. Sci. 7, 579674 (2020).
Davie, J. R. Inhibition of histone deacetylase activity by butyrate. J. Nutr. 133, 2485S–2493S (2003).
Pedersen, S. S., Prause, M., Williams, K., Barrès, R. & Billestrup, N. Butyrate inhibits IL-1β-induced inflammatory gene expression by suppression of NF-κB activity in pancreatic beta cells. J. Biol. Chem. 298, 102312 (2022).
Vinolo, M. A. R. et al. Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J. Nutr. Biochem. 22, 849–855 (2011).
Hu, M. et al. Short-chain fatty acids augment differentiation and function of human induced regulatory T cells. Int. J. Mol. Sci. 23, 5740 (2022).
Sun, J. et al. Butyrate as a promising therapeutic target in cancer: from pathogenesis to clinic (Review). Int. J. Oncol. 64, 44 (2024).
Wang, B., Morinobu, A., Horiuchi, M., Liu, J. & Kumagai, S. Butyrate inhibits functional differentiation of human monocyte-derived dendritic cells. Cell. Immunol. 253, 54–58 (2008).
Kaisar, M. M. M., Pelgrom, L. R., van der Ham, A. J., Yazdanbakhsh, M. & Everts, B. Butyrate conditions human dendritic cells to prime type 1 regulatory T cells via both histone deacetylase inhibition and G protein-coupled receptor 109A signaling. Front. Immunol. 8, 1429 (2017).
Macia, L. et al. Metabolite-sensing receptors GPR43 and GPR109A facilitate dietary fibre-induced gut homeostasis through regulation of the inflammasome. Nat. Commun. 6, 6734 (2015).
Schlatterer, K., Beck, C., Schoppmeier, U., Peschel, A. & Kretschmer, D. Acetate sensing by GPR43 alarms neutrophils and protects from severe sepsis. Commun. Biol. 4, 928 (2021).
Mirmonsef, P. et al. Short-chain fatty acids induce pro-inflammatory cytokine production alone and in combination with Toll-like receptor ligands. Am. J. Reprod. Immunol. 67, 391–400 (2012).
Kim, M. H., Kang, S. G., Park, J. H., Yanagisawa, M. & Kim, C. H. Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology 145, 396–406 (2013).
Ozturk, O. et al. Short-chain fatty acid levels in stools of patients with inflammatory bowel disease are lower than those in healthy subjects. Eur. J. Gastroenterol. Hepatol. 36, 890–896 (2024).
Machiels, K. et al. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 63, 1275–1283 (2014).
Harig, J. M., Soergel, K. H., Komorowski, R. A. & Wood, C. M. Treatment of diversion colitis with short-chain-fatty acid irrigation. N. Engl. J. Med. 320, 23–28 (1989).
Breuer, R. I. et al. Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial. Gut 40, 485–491 (1997).
Magnusson, M. K. et al. Impaired butyrate induced regulation of T cell surface expression of CTLA-4 in patients with ulcerative colitis. Int. J. Mol. Sci. 22, 3084 (2021).
Tolhurst, G. et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61, 364–371 (2012).
Karaki, S. et al. Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine. Cell Tissue Res. 324, 353–360 (2006).
Silva, Y. P., Bernardi, A. & Frozza, R. L. The role of short-chain fatty acids from gut microbiota in gut–brain communication. Front. Endocrinol. 11, 25 (2020).
Goswami, C., Iwasaki, Y. & Yada, T. Short-chain fatty acids suppress food intake by activating vagal afferent neurons. J. Nutr. Biochem. 57, 130–135 (2018).
Fukumoto, S. et al. Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284, R1269–R1276 (2003).
Fung, C. et al. Luminal short-chain fatty acids and 5-HT acutely activate myenteric neurons in the mouse proximal colon. Neurogastroenterol. Motil. 33, e14186 (2021).
Soret, R. et al. Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats. Gastroenterology 138, 1772–1782 (2010).
Kamath, P. S., Phillips, S. F. & Zinsmeister, A. R. Short-chain fatty acids stimulate ileal motility in humans. Gastroenterology 95, 1496–1502 (1988).
Waseem, M. R. et al. Associations of fecal short chain fatty acids with colonic transit, fecal bile acid, and food intake in irritable bowel syndrome. Clin. Transl. Gastroenterol. 14, e00541 (2023).
Akanji, A. O., Bruce, M. A. & Frayn, K. N. Effect of acetate infusion on energy expenditure and substrate oxidation rates in non-diabetic and diabetic subjects. Eur. J. Clin. Nutr. 43, 107–115 (1989).
Scholte, H. R. & Groot, P. H. Organ and intracellular localization of short-chain acyl-CoA synthetases in rat and guinea-pig. Biochim. Biophys. Acta 409, 283–296 (1975).
Manoli, I. et al. 1-13C-propionate breath testing as a surrogate endpoint to assess efficacy of liver-directed therapies in methylmalonic acidemia (MMA). Genet. Med. 23, 1522–1533 (2021).
Polyviou, T. et al. Randomised clinical study: inulin short-chain fatty acid esters for targeted delivery of short-chain fatty acids to the human colon. Aliment. Pharmacol. Ther. 44, 662–672 (2016).
Yoshida, H., Ishii, M. & Akagawa, M. Propionate suppresses hepatic gluconeogenesis via GPR43/AMPK signaling pathway. Arch. Biochem. Biophys. 672, 108057 (2019).
Zhao, Z.-H. et al. Sodium butyrate supplementation inhibits hepatic steatosis by stimulating liver kinase B1 and insulin-induced gene. Cell. Mol. Gastroenterol. Hepatol. 12, 857–871 (2021).
Sarkar, A. et al. Butyrate limits inflammatory macrophage niche in NASH. Cell Death Dis. 14, 332 (2023).
Trapecar, M. et al. Gut–liver physiomimetics reveal paradoxical modulation of IBD-related inflammation by short-chain fatty acids. Cell Syst. 10, 223–239 (2020).
Singh, V. et al. Dysregulated microbial fermentation of soluble fiber induces cholestatic liver cancer. Cell 175, 679–694 (2018).
Zhu, Y. et al. Dietary fiber intake and non-alcoholic fatty liver disease: the mediating role of obesity. Front. Public Health 10, 1038435 (2022).
Xia, Y. et al. Insoluble dietary fibre intake is associated with lower prevalence of newly-diagnosed non-alcoholic fatty liver disease in Chinese men: a large population-based cross-sectional study. Nutr. Metab. 17, 4 (2020).
Bugaut, M. & Bentéjac, M. Biological effects of short-chain fatty acids in nonruminant mammals. Annu. Rev. Nutr. 13, 217–241 (1993).
Haghikia, A. et al. Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism. Eur. Heart J. 43, 518–533 (2022).
Nishina, P. M. & Freedland, R. A. Effects of propionate on lipid biosynthesis in isolated rat hepatocytes. J. Nutr. 120, 668–673 (1990).
Canfora, E. E., Jocken, J. W. & Blaak, E. E. Short-chain fatty acids in control of body weight and insulin sensitivity. Nat. Rev. Endocrinol. 11, 577–591 (2015).
Pohl, K., Moodley, P. & Dhanda, A. The effect of increasing intestinal short-chain fatty acid concentration on gut permeability and liver injury in the context of liver disease: a systematic review. J. Gastroenterol. Hepatol. 37, 1498–1506 (2022).
Chambers, E. S. et al. The effects of dietary supplementation with inulin and inulin-propionate ester on hepatic steatosis in adults with non-alcoholic fatty liver disease. Diabetes Obes. Metab. 21, 372–376 (2019).
Yan, H. & Ajuwon, K. M. Mechanism of butyrate stimulation of triglyceride storage and adipokine expression during adipogenic differentiation of porcine stromovascular cells. PLoS ONE 10, e0145940 (2016).
Wang, L. et al. Adipocyte Gi signaling is essential for maintaining whole-body glucose homeostasis and insulin sensitivity. Nat. Commun. 11, 2995 (2020).
Tarini, J. & Wolever, T. M. S. The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects. Appl. Physiol. Nutr. Metab. 35, 9–16 (2010).
May, K. S. & den Hartigh, L. J. Modulation of adipocyte metabolism by microbial short-chain fatty acids. Nutrients 13, 3666 (2021).
Zaibi, M. S. et al. Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids. FEBS Lett. 584, 2381–2386 (2010).
Hu, J. et al. Short-chain fatty acid acetate stimulates adipogenesis and mitochondrial biogenesis via GPR43 in brown adipocytes. Endocrinology 157, 1881–1894 (2016).
Sahuri-Arisoylu, M. et al. Reprogramming of hepatic fat accumulation and ‘browning’ of adipose tissue by the short-chain fatty acid acetate. Int. J. Obes. 40, 955–963 (2016).
Moreno-Navarrete, J. M. et al. Gut microbiota interacts with markers of adipose tissue browning, insulin action and plasma acetate in morbid obesity. Mol. Nutr. Food Res. 62, 1700721 (2018).
Fernandes, J., Vogt, J. & Wolever, T. M. S. Intravenous acetate elicits a greater free fatty acid rebound in normal than hyperinsulinaemic humans. Eur. J. Clin. Nutr. 66, 1029–1034 (2012).
Tucker, L. A. Fiber intake and insulin resistance in 6374 adults: the role of abdominal obesity. Nutrients 10, 237 (2018).
Kynde, I. et al. Intake of total dietary sugar and fibre is associated with insulin resistance among Danish 8–10- and 14–16-year-old girls but not boys. European Youth Heart Studies I and II. Public Health Nutr. 13, 1669–1674 (2010).
Pingitore, A. et al. The diet-derived short chain fatty acid propionate improves beta-cell function in humans and stimulates insulin secretion from human islets in vitro. Diabetes Obes. Metab. 19, 257–265 (2017).
Pedersen, S. S., Ingerslev, L. R., Olsen, M., Prause, M. & Billestrup, N. Butyrate functions as a histone deacetylase inhibitor to protect pancreatic beta cells from IL-1β-induced dysfunction. FEBS J. 291, 566–583 (2024).
Bridgeman, S., Ellison, G., Newsholme, P. & Mamotte, C. The HDAC inhibitor butyrate impairs β cell function and activates the disallowed gene hexokinase I. Int. J. Mol. Sci. 22, 13330 (2021).
Perry, R. J. et al. Acetate mediates a microbiome–brain–β-cell axis to promote metabolic syndrome. Nature 534, 213–217 (2016).
Oldendorf, W. H. Carrier-mediated blood–brain barrier transport of short-chain monocarboxylic organic acids. Am. J. Physiol. 224, 1450–1453 (1973).
Bachmann, C., Colombo, J.-P. & Berüter, J. Short chain fatty acids in plasma and brain: quantitative determination by gas chromatography. Clin. Chim. Acta 92, 153–159 (1979).
Byrne, C. S., Chambers, E. S., Morrison, D. J. & Frost, G. The role of short chain fatty acids in appetite regulation and energy homeostasis. Int. J. Obes. 39, 1331–1338 (2015).
Sun, J. et al. Effect of Clostridium butyricum against microglia-mediated neuroinflammation in Alzheimer’s disease via regulating gut microbiota and metabolites butyrate. Mol. Nutr. Food Res. 64, e1900636 (2020).
Guo, T.-T. et al. Neuroprotective effects of sodium butyrate by restoring gut microbiota and inhibiting TLR4 signaling in mice with MPTP-induced Parkinson’s disease. Nutrients 15, 930 (2023).
Erny, D. et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 18, 965–977 (2015).
Wei, Y., Melas, P. A., Wegener, G., Mathé, A. A. & Lavebratt, C. Antidepressant-like effect of sodium butyrate is associated with an increase in TET1 and in 5-hydroxymethylation levels in the Bdnf gene. Int. J. Neuropsychopharmacol. 18, pyu032 (2015).
Valvassori, S. S. et al. Sodium butyrate, a histone deacetylase inhibitor, reverses behavioral and mitochondrial alterations in animal models of depression induced by early- or late-life stress. Curr. Neurovasc. Res. 12, 312–320 (2015).
Sun, J. et al. Antidepressant-like effects of sodium butyrate and its possible mechanisms of action in mice exposed to chronic unpredictable mild stress. Neurosci. Lett. 618, 159–166 (2016).
van de Wouw, M. et al. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain–gut axis alterations. J. Physiol. 596, 4923–4944 (2018).
Byrne, C. S. et al. Increased colonic propionate reduces anticipatory reward responses in the human striatum to high-energy foods. Am. J. Clin. Nutr. 104, 5–14 (2016).
Demigné, C. et al. Effect of propionate on fatty acid and cholesterol synthesis and on acetate metabolism in isolated rat hepatocytes. Br. J. Nutr. 74, 209–219 (1995).
Lu, B. et al. Propionate induces energy expenditure via browning in mesenteric adipose tissue. J. Clin. Endocrinol. Metab. 111, 256–267 (2025).
Hu, S., Kuwabara, R., de Haan, B. J., Smink, A. M. & de Vos, P. Acetate and butyrate improve β-cell metabolism and mitochondrial respiration under oxidative stress. Int. J. Mol. Sci. 21, 1542 (2020).
Knudsen, K. E. B. et al. Impact of diet-modulated butyrate production on intestinal barrier function and inflammation. Nutrients 10, 1499 (2018).
Hallert, C. et al. Increasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot study. Inflamm. Bowel Dis. 9, 116–121 (2003).
Lu, Y. et al. Short chain fatty acids prevent high-fat-diet-induced obesity in mice by regulating G protein-coupled receptors and gut microbiota. Sci. Rep. 6, 37589 (2016).
Brooks, L. et al. Fermentable carbohydrate stimulates FFAR2-dependent colonic PYY cell expansion to increase satiety. Mol. Metab. 6, 48–60 (2017).
den Besten, G. et al. Short-chain fatty acids protect against high-fat diet-induced obesity via a PPARγ-dependent switch from lipogenesis to fat oxidation. Diabetes 64, 2398–2408 (2015).
Li, Z. et al. Butyrate reduces appetite and activates brown adipose tissue via the gut–brain neural circuit. Gut 67, 1269–1279 (2018).
Lin, H. V. et al. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS ONE 7, e35240 (2012).
Jiao, A. et al. Sodium acetate, propionate, and butyrate reduce fat accumulation in mice via modulating appetite and relevant genes. Nutrition 87–88, 111198 (2021).
Sanaka, M., Yamamoto, T., Anjiki, H., Nagasawa, K. & Kuyama, Y. Effects of agar and pectin on gastric emptying and post-prandial glycaemic profiles in healthy human volunteers. Clin. Exp. Pharmacol. Physiol. 34, 1151–1155 (2007).
Yu, K., Ke, M.-Y., Li, W.-H., Zhang, S.-Q. & Fang, X.-C. The impact of soluble dietary fibre on gastric emptying, postprandial blood glucose and insulin in patients with type 2 diabetes. Asia Pac. J. Clin. Nutr. 23, 210–218 (2014).
Slaughter, S. L., Ellis, P. R., Jackson, E. C. & Butterworth, P. J. The effect of guar galactomannan and water availability during hydrothermal processing on the hydrolysis of starch catalysed by pancreatic α-amylase. Biochim. Biophys. Acta 1571, 55–63 (2002).
Grundy, M. M.-L. et al. Re-evaluation of the mechanisms of dietary fibre and implications for macronutrient bioaccessibility, digestion and postprandial metabolism. Br. J. Nutr. 116, 816–833 (2016).
Davis, J. N., Alexander, K. E., Ventura, E. E., Toledo-Corral, C. M. & Goran, M. I. Inverse relation between dietary fiber intake and visceral adiposity in overweight Latino youth. Am. J. Clin. Nutr. 90, 1160–1166 (2009).
Gibson, R. et al. Intakes and food sources of dietary fibre and their associations with measures of body composition and inflammation in UK adults: cross-sectional analysis of the airwave health monitoring study. Nutrients 11, 1839 (2019).
Pedersen, C. et al. Gut hormone release and appetite regulation in healthy non-obese participants following oligofructose intake. A dose-escalation study. Appetite 66, 44–53 (2013).
Nilsson, A., Johansson, E., Ekström, L. & Björck, I. Effects of a brown beans evening meal on metabolic risk markers and appetite regulating hormones at a subsequent standardized breakfast: a randomized cross-over study. PLoS ONE 8, e59985 (2013).
Guess, D. N., Dornhorst, A. & Frost, S. G. P159. Fermentable carbohydrate decreases food intake and promotes weight loss in overweight subjects with prediabetes. Diabet. Med. 30, 77 (2013).
Daud, N. M. et al. The impact of oligofructose on stimulation of gut hormones, appetite regulation and adiposity. Obesity 22, 1430–1438 (2014).
Pugh, J. E. et al. Increase in colonic PRopionate as a method of prEVENTing weight gain over 12 months in adults aged 20–40 years (iPREVENT): a multi-centre, double-blind, randomised, parallel-group trial. EClinicalMedicine 76, 102844 (2024).
Neis, E. P. et al. Distal versus proximal intestinal short-chain fatty acid release in man. Gut 68, 764–765 (2019).
Freeland, K. R. & Wolever, T. M. S. Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-α. Br. J. Nutr. 103, 460–466 (2010).
Canfora, E. E. et al. Colonic infusions of short-chain fatty acid mixtures promote energy metabolism in overweight/obese men: a randomized crossover trial. Sci. Rep. 7, 2360 (2017).
Bouter, K. et al. Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects. Clin. Transl. Gastroenterol. 9, 155 (2018).
Canfora, E. E. et al. Fiber mixture-specific effect on distal colonic fermentation and metabolic health in lean but not in prediabetic men. Gut Microbes 14, 2009297 (2022).
Shchepinova, M. M., Hanyaloglu, A. C., Frost, G. S. & Tate, E. W. Chemical biology of noncanonical G protein-coupled receptor signaling: toward advanced therapeutics. Curr. Opin. Chem. Biol. 56, 98–110 (2020).
Maslowski, K. M. et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461, 1282–1286 (2009).
Namour, F. et al. Safety, pharmacokinetics and pharmacodynamics of GLPG0974, a potent and selective FFA2 antagonist, in healthy male subjects. Br. J. Clin. Pharmacol. 82, 139–148 (2016).
Samuel, B. S. et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc. Natl Acad. Sci. USA 105, 16767–16772 (2008).
Tang, C. et al. Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes. Nat. Med. 21, 173–177 (2015).
Sonnenburg, E. D. et al. Diet-induced extinctions in the gut microbiota compound over generations. Nature 529, 212–215 (2016).
Penumutchu, S., Korry, B. J., Hewlett, K. & Belenky, P. Fiber supplementation protects from antibiotic-induced gut microbiome dysbiosis by modulating gut redox potential. Nat. Commun. 14, 5161 (2023).
Erny, D. et al. Microbiota-derived acetate enables the metabolic fitness of the brain innate immune system during health and disease. Cell Metab. 33, 2260–2276 (2021).
Ghosh, S. et al. Short chain acyl-CoA dehydrogenase deficiency and short-term high-fat diet perturb mitochondrial energy metabolism and transcriptional control of lipid-handling in liver. Nutr. Metab. 13, 17 (2016).
Wu, Q. et al. Integrated analysis of expression and prognostic values of acyl-CoA dehydrogenase short-chain in colorectal cancer. Int. J. Med. Sci. 18, 3631–3643 (2021).
Wolever, T. M., Brighenti, F., Royall, D., Jenkins, A. L. & Jenkins, D. J. Effect of rectal infusion of short chain fatty acids in human subjects. Am. J. Gastroenterol. 84, 1027–1033 (1989).
Liu, H. et al. Unlocking the power of short-chain fatty acids in ameliorating intestinal mucosal immunity: a new porcine nutritional approach. Front. Cell. Infect. Microbiol. 14, 1449030 (2024).
Zhou, H. et al. Exogenous infusion of short-chain fatty acids can improve intestinal functions independently of the gut microbiota. J. Anim. Sci. 98, skaa371 (2020).
Eaton, S. B. The ancestral human diet: what was it and should it be a paradigm for contemporary nutrition? Proc. Nutr. Soc. 65, 1–6 (2006).
McNeil, N. I. The contribution of the large intestine to energy supplies in man. Am. J. Clin. Nutr. 39, 338–342 (1984).
Frankel, W. L. et al. Mediation of the trophic effects of short-chain fatty acids on the rat jejunum and colon. Gastroenterology 106, 375–380 (1994).
Peng, L., Li, Z.-R., Green, R. S., Holzman, I. R. & Lin, J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J. Nutr. 139, 1619–1625 (2009).
Chang, P. V., Hao, L., Offermanns, S. & Medzhitov, R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc. Natl Acad. Sci. USA 111, 2247–2252 (2014).
Kimura, I., Ichimura, A., Ohue-Kitano, R. & Igarashi, M. Free fatty acid receptors in health and disease. Physiol. Rev. 100, 171–210 (2020).
Lubin, J.-B. et al. Arresting microbiome development limits immune system maturation and resistance to infection in mice. Cell Host Microbe 31, 554–570 (2023).